252 related articles for article (PubMed ID: 32463308)
21. Race to find COVID-19 treatments accelerates.
Kupferschmidt K; Cohen J
Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
[No Abstract] [Full Text] [Related]
22. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?
Allam MF; Andraous F
Cent Eur J Public Health; 2020 Sep; 28(3):246-247. PubMed ID: 32997483
[No Abstract] [Full Text] [Related]
23. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
D'Acquarica I; Agranat I
Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
[No Abstract] [Full Text] [Related]
24. Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae.
Hamm BS; Rosenthal LJ
Psychosomatics; 2020; 61(6):597-606. PubMed ID: 32800347
[TBL] [Abstract][Full Text] [Related]
25. [Hydroxychloroquine. Cardiology's viewpoint in times of coronavirus pandemic].
Zaidel EJ; Wyss Quintana FS; Sosa Liprandi Á; Mendoza I; Márquez MF; Nuñez E; Barbosa M; Baranchuk A
Medicina (B Aires); 2020; 80(3):271-274. PubMed ID: 32442941
[TBL] [Abstract][Full Text] [Related]
26. The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks.
Yahya AS; Khawaja S; Chukwuma J
Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32441496
[No Abstract] [Full Text] [Related]
27. What is the role of rheumatologists in the era of COVID-19?
Marotto D; Sarzi-Puttini P
Autoimmun Rev; 2020 Jun; 19(6):102539. PubMed ID: 32251716
[No Abstract] [Full Text] [Related]
28. Chloroquine and its derivatives in the management of COVID-19: A scoping review.
Pimentel J; Andersson N
Biomedica; 2020 Oct; 40(Supl. 2):80-95. PubMed ID: 33152192
[TBL] [Abstract][Full Text] [Related]
29. Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.
Jakhar D; Kaur I
Nat Med; 2020 May; 26(5):632. PubMed ID: 32269358
[No Abstract] [Full Text] [Related]
30. Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.
White CM; Hernandez AV
J Clin Pharmacol; 2020 Aug; 60(8):949-953. PubMed ID: 32530493
[No Abstract] [Full Text] [Related]
31. The COVID-19 Pandemic and Mayo Clinic Proceedings.
Nath KA
Mayo Clin Proc; 2020 May; 95(5):835-836. PubMed ID: 32370843
[No Abstract] [Full Text] [Related]
32. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
[No Abstract] [Full Text] [Related]
33. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
Yazdany J; Kim AHJ
Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
[TBL] [Abstract][Full Text] [Related]
34. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
Sargin G; Yavaşoğlu Sİ; Yavasoglu I
Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306
[No Abstract] [Full Text] [Related]
35. QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine: A letter to the editor.
Danjuma MI; Sinha U; Fatima H; Mohamed MFH; Nathoe H
Eur J Clin Invest; 2020 Nov; 50(11):e13407. PubMed ID: 32918829
[No Abstract] [Full Text] [Related]
36. [Potential harms associated with 4-aminoquinoline treatment].
Svensson M
Lakartidningen; 2020 Apr; 117():. PubMed ID: 32365215
[TBL] [Abstract][Full Text] [Related]
37. Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
Ibáñez S; Martínez O; Valenzuela F; Silva F; Valenzuela O
Clin Rheumatol; 2020 Aug; 39(8):2461-2465. PubMed ID: 32495226
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 and Depression.
Shader RI
Clin Ther; 2020 Jun; 42(6):962-963. PubMed ID: 32362345
[TBL] [Abstract][Full Text] [Related]
39. Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy.
Pati S; Houston T
Epilepsy Res; 2020 Sep; 165():106399. PubMed ID: 32559589
[TBL] [Abstract][Full Text] [Related]
40. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
